Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Escom (Scientific and Production Concern ESCOM) is a leading Russian pharmaceutical company specializing in the manufacture of infusion and injection solutions, such as sodium chloride and glucose. Founded in 1998 and headquartered in Stavropol, Russia, the company is the largest producer of infusion solutions in the south of Russia, with over 80% of its products included in the Russian List of Vital and Essential Drugs (VED). Escom operates advanced GMP-compliant manufacturing facilities and supplies its products to healthcare institutions across Russia and neighboring countries. Despite facing financial restructuring and bankruptcy proceedings in recent years, the company remains an active and critical player in the Russian pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Escom.